A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
Baptist Health South Florida
Barbara Ann Karmanos Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Jonsson Comprehensive Cancer Center
Columbia University
Thomas Jefferson University
City of Hope Medical Center
Second Affiliated Hospital of Guangzhou Medical University
Northwestern University
Mayo Clinic
Quadriga Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Emory University
Celgene
IGF Oncology, LLC
Duke University
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Angiochem Inc
Dana-Farber Cancer Institute
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jules Bordet Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center